ID   P4K2B_RAT               Reviewed;         477 AA.
AC   Q5XIL2;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-NOV-2004, sequence version 1.
DT   24-JUL-2024, entry version 107.
DE   RecName: Full=Phosphatidylinositol 4-kinase type 2-beta;
DE            EC=2.7.1.67 {ECO:0000250|UniProtKB:Q8TCG2};
DE   AltName: Full=Phosphatidylinositol 4-kinase type II-beta;
GN   Name=Pi4k2b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Together with PI4K2A and the type III PI4Ks (PIK4CA and
CC       PIK4CB) it contributes to the overall PI4-kinase activity of the cell.
CC       This contribution may be especially significant in plasma membrane,
CC       endosomal and Golgi compartments. The phosphorylation of
CC       phosphatidylinositol (PI) to PI4P is the first committed step in the
CC       generation of phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor
CC       of the second messenger inositol 1,4,5-trisphosphate (InsP3).
CC       Contributes to the production of InsP3 in stimulated cells and is
CC       likely to be involved in the regulation of vesicular trafficking.
CC       {ECO:0000250|UniProtKB:Q8TCG2}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a
CC         1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + ADP +
CC         H(+); Xref=Rhea:RHEA:19877, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57880, ChEBI:CHEBI:58178, ChEBI:CHEBI:456216;
CC         EC=2.7.1.67; Evidence={ECO:0000250|UniProtKB:Q8TCG2};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19878;
CC         Evidence={ECO:0000250|UniProtKB:Q8TCG2};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q8TCG2}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q8TCG2}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q8TCG2}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8TCG2}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q8TCG2}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q8TCG2}. Note=Mainly cytosolic, association with
CC       membranes of the Golgi, endoplasmic and plasma membrane is stimulated
CC       by active RAC1. Association with early endosomes has not been
CC       confirmed. {ECO:0000250|UniProtKB:Q8TCG2}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. Type II PI4K
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC083668; AAH83668.1; -; mRNA.
DR   RefSeq; NP_001005883.1; NM_001005883.1.
DR   AlphaFoldDB; Q5XIL2; -.
DR   SMR; Q5XIL2; -.
DR   STRING; 10116.ENSRNOP00000005349; -.
DR   PhosphoSitePlus; Q5XIL2; -.
DR   SwissPalm; Q5XIL2; -.
DR   PaxDb; 10116-ENSRNOP00000005349; -.
DR   Ensembl; ENSRNOT00000005349.6; ENSRNOP00000005349.3; ENSRNOG00000003924.7.
DR   Ensembl; ENSRNOT00055018075; ENSRNOP00055014518; ENSRNOG00055010692.
DR   Ensembl; ENSRNOT00060028812; ENSRNOP00060023185; ENSRNOG00060016830.
DR   Ensembl; ENSRNOT00065004201; ENSRNOP00065002988; ENSRNOG00065002996.
DR   GeneID; 305419; -.
DR   KEGG; rno:305419; -.
DR   AGR; RGD:1359515; -.
DR   CTD; 55300; -.
DR   RGD; 1359515; Pi4k2b.
DR   eggNOG; KOG2381; Eukaryota.
DR   GeneTree; ENSGT00390000010434; -.
DR   HOGENOM; CLU_032516_1_0_1; -.
DR   InParanoid; Q5XIL2; -.
DR   OMA; GSTAEMN; -.
DR   OrthoDB; 1332545at2759; -.
DR   PhylomeDB; Q5XIL2; -.
DR   TreeFam; TF314740; -.
DR   Reactome; R-RNO-1483248; Synthesis of PIPs at the ER membrane.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-RNO-1660516; Synthesis of PIPs at the early endosome membrane.
DR   PRO; PR:Q5XIL2; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000003924; Expressed in duodenum and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IBA:GO_Central.
DR   GO; GO:0004430; F:1-phosphatidylinositol 4-kinase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0007032; P:endosome organization; IBA:GO_Central.
DR   GO; GO:0007030; P:Golgi organization; IBA:GO_Central.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; ISS:UniProtKB.
DR   Gene3D; 1.10.1070.20; -; 1.
DR   InterPro; IPR039756; Lsb6/PI4K2.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   PANTHER; PTHR12865:SF6; PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-BETA; 1.
DR   PANTHER; PTHR12865; PHOSPHATIDYLINOSITOL 4-KINASE TYPE-II; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell membrane; Cytoplasm; Endoplasmic reticulum; Endosome;
KW   Golgi apparatus; Kinase; Lipid metabolism; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..477
FT                   /note="Phosphatidylinositol 4-kinase type 2-beta"
FT                   /id="PRO_0000285166"
FT   DOMAIN          116..447
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1..80
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          122..128
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          149..151
FT                   /note="Important for substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   REGION          157..170
FT                   /note="Important for interaction with membranes"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   REGION          260..268
FT                   /note="Important for interaction with membranes"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   REGION          297..305
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          338..358
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          353..362
FT                   /note="Important for interaction with membranes"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   BINDING         129
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TCG2"
FT   BINDING         144
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TCG2"
FT   BINDING         253..256
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TCG2"
FT   BINDING         267..268
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TCG2"
FT   BINDING         340
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TCG2"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8TCG2"
SQ   SEQUENCE   477 AA;  54464 MW;  BCC6EECB4594F652 CRC64;
     MPEPPRDIMA EACEATRPSE DEDEEREPLL PRVAWAQPRR GAPGSAVRLQ ADQGAAVLRE
     PATEEPPVVS EDRSISASLS TELDRTRNAV SETNTFLEDP EFADVVLKAE QAIEIGVFPE
     RISQGSSGSY FVKDSKRTII GVFKPKSEEP YGQLNPKWTK YVHKVCCPCC FGRGCLLPNQ
     GYLSEAGAYL VDTKLQLGIV PKTKVVWLVS ETFNYSAIDR AKSRGKKYAL EKVPKVGRKF
     HRIGLPPKIG SFQLFVKDYK EAEYWLRRFE AEPLPENIRK QFQSQFERLV ILDYIIRNTD
     RGNDNWLVKY DEMKYAKKIE SEESNWIDDK QLLIRIAAID NGLAFPFKHP DEWRAYPFHW
     AWLPQAKVPF SEETRNLILP FISDMNFVQD LCEDLYELFK TDKGFDRAAF ESQMSVMRGQ
     ILNLTQALRD GKSPMQLAQM PCVIVECSKS GGQGRVVHLG SSFTQTVHCR KPFFSSW
//
